• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Abstract 201: Gemfibrozil In Combination With Statin Is Associated With Reduction In All Cause Mortality: A Retrospective Cohort Study Session Title: Poster Session II
Conclusion: Combination of gemfibrozil with statin is associated with greater reduction in all cause mortality compared to statins alone.Keywords: gemfibrozil, mortality
Source: Circulation: Cardiovascular Quality and Outcomes - June 2, 2014 Category: Cardiology Authors: Aryal, S. R., Newman, W. Tags: Session Title: Poster Session II Source Type: research

Abstract 304: Nonfatal Outcomes Following Incident Atrial Fibrillation: A Community Study Session Title: Poster Session III
Conclusions: In the community, adverse outcomes are frequent after AF, and HF occurs more frequently than IS/TIA. Risk factors differed for IS/TIA and HF, suggesting that pathways to the occurrence of these outcomes, as well as prevention strategies, may differ. Finally, the occurrence of these outcomes did not decline over the last decade, highlighting the importance of continued rigorous surveillance of adverse outcomes in AF.
Source: Circulation: Cardiovascular Quality and Outcomes - June 2, 2014 Category: Cardiology Authors: Chamberlain, A. M., Gersh, B. J., Alonso, A., Brown, R. D., Weston, S. A., Roger, V. L. Tags: Session Title: Poster Session III Source Type: research

Abstract 11: Compliance With Risk Factor Optimization and Medical Therapy in Patients With Peripheral Vascular Disease (Peripheral Artery and Ischemic Cerebrovascular Disease) Compared to Ischemic Heart Disease. Session Title: Concurrent Session IIB: Oral Abstracts - Quality of Care
Conclusions: Compliance with OMT was low in all patients. Patients with PAD or ICVD were less likely to receive OMT compared with IHD. Our results suggest potential for improvement in OMT for all CVD patients especially those with PAD and ICVD.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Hira, R. S., Pokharel, Y., Cowart, J., Akeroyd, J. M., Ramsey, D., Nambi, V., Jneid, H., Deswal, A., Denktas, A., Ballantyne, C. M., Petersen, L. A., Virani, S. S. Tags: Session Title: Concurrent Session IIB: Oral Abstracts - Quality of Care Source Type: research

Abstract 246: Potential for Healthy Survivor Bias Among Symptomatic Peripheral Artery Disease Patients with Long Follow-up: Comparing 1 Year Versus 3 Year Post-Index Outcomes Session Title: Poster Session II
Conclusions: A comparative review of findings from these SPAD studies has revealed that the ‘healthy survivor’ bias may have led to an under-estimation of SPAD outcomes in the 1-year pre-/3-year post-index. A replication of the 1-year pre-/3-year post-index using a data source with mortality data is warranted.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Chase, M., Friedman, H., Navaratnam, P., Heithoff, K., Simpson, R. J. Tags: Session Title: Poster Session II Source Type: research

Abstract 250: Real-world Rates and Costs of Heart Failure Events Among Patients with Hyperlipidemia Session Title: Poster Session II
Conclusions: The rate and recurrence of heart failure among hyperlipidemic patients is very high and the long term healthcare costs substantial in this real-world 2-year study.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Fox, K. M., Punekar, R. S., Richhariya, A., Fisher, M. D., Gandra, S. R., Cziraky, M. J., Toth, P. P. Tags: Session Title: Poster Session II Source Type: research

Abstract 355: The Economic and Clinical Burden of High Risk Symptomatic Peripheral Artery Disease Session Title: Poster Session III
Conclusions: Effective secondary prevention therapies may reduce morbidity and costs associated with these high risk groups.
Source: Circulation: Cardiovascular Quality and Outcomes - April 29, 2015 Category: Cardiology Authors: Chase, M., Friedmann, H., Navaratnam, P., Heithoff, K., Simpson, R. J. Tags: Session Title: Poster Session III Source Type: research

Clinical Prediction Models for Cardiovascular Disease: Tufts Predictive Analytics and Comparative Effectiveness Clinical Prediction Model Database Original Articles
Conclusions— There is an abundance of CPMs available for a wide assortment of cardiovascular disease conditions, with substantial redundancy in the literature. The comparative performance of these models, the consistency of effects and risk estimates across models and the actual and potential clinical impact of this body of literature is poorly understood.
Source: Circulation: Cardiovascular Quality and Outcomes - July 21, 2015 Category: Cardiology Authors: Wessler, B. S., Lai YH, L., Kramer, W., Cangelosi, M., Raman, G., Lutz, J. S., Kent, D. M. Tags: Congestive, Risk Factors Original Articles Source Type: research

Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey Original Articles
Conclusions— Favorable CRF profile is associated with significantly lower medical expenditure and healthcare utilization among individuals with and without established CVD.
Source: Circulation: Cardiovascular Quality and Outcomes - March 15, 2016 Category: Cardiology Authors: Valero-Elizondo, J., Salami, J. A., Ogunmoroti, O., Osondu, C. U., Aneni, E. C., Malik, R., Spatz, E. S., Rana, J. S., Virani, S. S., Blankstein, R., Blaha, M. J., Veledar, E., Nasir, K. Tags: Cardiovascular Disease, Lifestyle, Risk Factors Original Articles Source Type: research

Abstract 112: Adherence and Persistence with Statins in Patients with ASCVD Session Title: Abstract Poster Session I and Reception
Conclusions: While patients remained on their first statin (or ezetimibe) therapy for a substantial period of time, a large proportion of patients eventually discontinue therapy. Overall, adherence was high, indicating that ASCVD patients are compliant with their LLT. Interventions and new treatments to improve lipid lowering therapy seem necessary in patients with ASCVD.
Source: Circulation: Cardiovascular Quality and Outcomes - February 26, 2016 Category: Cardiology Authors: Burke, J. P., Paoli, C. J., McPheeters, J., Gandra, S. R., Simpson, R. J. Tags: Session Title: Abstract Poster Session I and Reception Source Type: research

Abstract 160: Health-related Quality of Life (HRQoL) Associated with Cardiovascular Disease (CVD) and Comorbidities in Patients with Diabetes Session Title: Abstract Poster Session I and Reception
Conclusions: The results provided may be useful to estimate the impact of diabetes-related and CVD comorbid conditions on utility for public health and cost-effectiveness analyses. Limitations: Estimates reflect annual or chronic impacts because survey timing limited the ability to estimate acute effects. This research was unable to differentiate between type 1 and type 2 DM.
Source: Circulation: Cardiovascular Quality and Outcomes - February 26, 2016 Category: Cardiology Authors: Sullivan, P., Ghushchyan, V. Tags: Session Title: Abstract Poster Session I and Reception Source Type: research

Abstract 244: Sex-based Differences in Economic and Health-related Burden of Depression on Adults With Cardiovascular Disease Session Title: Abstract Poster Session II
Conclusion: CVD patients, especially women, were more likely to have depression, and had considerable higher medical expenditures. The results reinforce the paramount importance of assessing and managing depression among those with CVD to favorably impact healthcare costs.
Source: Circulation: Cardiovascular Quality and Outcomes - February 26, 2016 Category: Cardiology Authors: Valero-Elizondo, J., Salami, J. A., Ogunmoroti, O., Ali, S., Arrieta, A., Spatz, E. S., Rana, J. S., Virani, S. S., Blankstein, R., Blaha, M. J., Veledar, E., Nasir, K. Tags: Session Title: Abstract Poster Session II Source Type: research

Abstract 150: Machine Learning Methodology Predicts Comorbidities are Associated With Increased Total Healthcare Costs Among Patients With Severe Peripheral Artery Disease Session Title: Poster Session II
Conclusion: In this study, the presence of chronic ulcers in the lower extremities and CKD were two factors most predictive of increased all-cause total HC in a geographically diverse population of severe PAD patients.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Berger, J. S., Haskell, L., Ting, W., Lurie, F., Eapen, Z., Valko, M., Alas, V., Rich, K., Crivera, C., Schein, J. Tags: Session Title: Poster Session II Source Type: research

Abstract 195: Statin Use and Its Facility Level Variation in Patients With Ischemic Cerebrovascular Disease: Insights From the Department of Veterans Affairs Session Title: Poster Session II
Conclusions: The use of statin and especially guideline-recommended statin intensity is suboptimal in ICVD patients, especially patients without concomitant IHD or PAD. There is significant facility-level variation in receipt of guideline directed statin therapy in ICVD patients. Interventions are needed to improve guideline directed moderate to high-intensity statin use and reduce variation in care in this high risk group.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: McBride, C. L., Akaroyd, J., Ramsey, D. J., Nambi, V., Nasir, K., Michos, E. D., Birtcher, K. K., Morris, P. B., Bittner, V. A., Ballentyne, C. M., Peterson, L. A., Virani, S. S. Tags: Session Title: Poster Session II Source Type: research

Pages: 1  2